Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study

Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study

Yusuke Kitagawa, Hiroki Osumi, Eiji Shinozaki, Yumiko Ota, Izuma Nakayama, Takeshi Suzuki, Takeru Wakatsuki, Takashi Ichimura, Mariko Ogura, Akira Ooki, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin, Kensei YamaguchiDepartment of Gastroenterology, Cancer Institute Hospital, Japanese Foundation fo...

Full description

Bibliographic Details
Main Authors: Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Cancer Management and Research
Subjects:
amrubicin monotherapy
platinum refractory
gastrointestinal neuroendocrine carcinoma
Online Access:https://www.dovepress.com/safety-and-efficacy-of-amrubicin-monotherapy-in-patients-with-platinum-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/safety-and-efficacy-of-amrubicin-monotherapy-in-patients-with-platinum-peer-reviewed-article-CMAR

Similar Items